Thank you for the Registration! Please check your mailbox. Simply click on the button in your email and you are successfully logged in.
With your Log-In you can save your favorite events to you calendar and give RSVP to certain events.
No email in your mailbox? Please check your spam folder or try again.
It seems you haven't registered yet!
Register now and become part of the event and the global Falling Walls Community. We will send you news about this and future events and keep you updated about the most exciting breakthroughs in science.
You can withdraw your consent at any time free of charge and without giving reasons.
Enter your email for free registration or login
Simply enter your email address to sign up for free for the event or log in to your account. You will directly receive an email allowing you to log in without a password.
Login failed
You want to login with an account which needs advanced authentification via password. Please use the regular login interface for this email address or register with a different email address for participating in the summit passwordless.
Life Sciences
Insights into AI, Robotic & Quantum
Digital
Deutsch
Recording
Lecture
Panel Discussion
Künstliche Intelligenz, Organoide, Tiermodelle – Neue Konzepte in der Biomedizin (DE)
Max-Delbrück-Centrum für Molekulare Medizin
| Thomas Sommer, Michael Gotthardt, Uta Höpken, Agnieszka Rybak-Wolf
Was sind die vielversprechendsten Wege, Therapien für Patient*innen zu entwickeln? Unsere Expert*innen berichten und beantworten Ihre Fragen.
Es gibt mehr als einen Weg, neue Therapien für Patientinnen und Patienten zu entwickeln. Hier präsentieren und diskutieren wir Beispiele aus der MDC-Forschung, die verschiedene Strategien und Technologien kombinieren – von Künstlicher Intelligenz (KI) und Omics-Technologien über Organoide und menschliche Gewebeproben bis hin zu Tiermodellen, den 3R-Prinzipien und klinischer Forschung. Und wir stellen vor, was unser neues präklinisches Forschungszentrum PRC damit zu tun hat.
Unsere Expertinnen und Experten berichten und beantworten Ihre Fragen im Chat.
PANEL DISCUSSION PER ZOOM. BITTE ANMELDEN.
Dies ist ein digitales Event. Bitte melden Sie sich bis zum 2. November, 17 Uhr, hier an. Den Link zum Online-Event erhalten Sie durch den Organisator ca. eine Woche vor Veranstaltungsbeginn per E-Mail.
Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)
Scientific Director (interim)
Thomas Sommer is interim Scientific Director of the MDC. The cell biologist researches protein quality control and holds a chair at HU Berlin. He is one of the founding coordinators of Berlin Research 50 and is on the board of the DZHK and EU-LIFE. He investigates scientific misconduct and is an expert reviewer for the DFG. He became a member of the EMBO in 2003, won the Science Prize of the German Technion Society in 2012, and has been a Visiting Professor at the Technion in Israel since 2017.
More events with Thomas Sommer
Mon | Nov 02, 2020 | 17.00 - 18.30 Europe/Berlin Time
Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)
Head of Research Group “Neuromuscular and Cardiovascular Cell Biology”
After studying medicine in Heidelberg and Berlin, Professor Michael Gotthardt did his postoc at UT Southwestern in Dallas, started his independent lab at Washington State University and moved back to the Max Delbrück Center in 2002. He studies titin, the largest protein in the human body, and how it relates to cardiovascular disease. His work extends from basic molecular and cell biology to developing novel therapies. He is the recipient of the Sofia Kovalevskaya Award and an ERC Starting Grant.
David Ausserhofer - MDC
Uta Höpken
Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)
Group Leader “Microenvironmental Regulation in Autoimmunity and Cancer”
Dr. Uta Höpken is an immunologist who investigates how lymphoma develops and how it manages to escape the immune system. Another research focus is the development of novel CAR-T cell products for the immunotherapeutic treatment of blood cancer. Currently, Höpken is an elected member of the Steering Committee on Clinical Translational Sciences at the Berlin Institute of Health (BIH) and a scientific adviser in the field of immuno-oncology at the German Cancer Society (DKG).
Felix Petermann, MDC
Agnieszka Rybak-Wolf
Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)
Head of the Technology Platform Organoids
Dr. Agnieszka Rybak-Wolf heads the MDC’s newly established Organoids Platform. She previously studied the expression and function of regulatory RNAs, such as miRNAs and circular RNAs, during neuronal specification and mammalian brain development. Her current research employs a brain organoid model to study human neurodegenerative diseases, with the goal of elucidating pathogenic mechanisms underlying their development and identifying potential therapeutic targets for disease treatment.
More events with Agnieszka Rybak-Wolf
Wed | Nov 11, 2020 | 16.00 - 17.30 Europe/Berlin Time
Thank you for the Registration! Please check your mailbox. Simply click on the button in your email and you are successfully logged in.
With your Log-In you can save your favorite events to you calendar and give RSVP to certain events.
No email in your mailbox? Please check your spam folder or try again.
It seems you haven't registered yet!
Register now and become part of the event and the global Falling Walls Community. We will send you news about this and future events and keep you updated about the most exciting breakthroughs in science.
You can withdraw your consent at any time free of charge and without giving reasons.
Enter your email for free registration or login
Simply enter your email address to sign up for free for the event or log in to your account. You will directly receive an email allowing you to log in without a password.
Login failed
You want to login with an account which needs advanced authentification via password. Please use the regular login interface for this email address or register with a different email address for participating in the summit passwordless.
We use cookies and other technologies to collect data about your use of our site and about your browser, device and location. We process this data to help us understand how the site is used and to personalize our content and the advertising you see on this and other sites we also share this data with advertising, social media and analytics partners for the same purposes. By choosing “Accept All” you agree that we store cookies on your device and process the data for the aforementioned purposes . You may revoke your consent at any time by choosing the respective settings. For more information on the processing of personal data and what specific services we use see our Privacy Policy
Privacy Preference Center
We use cookies and other technologies to collect data about your use of our site and about your browser, device and location. We process this data to help us understand how the site is used and to personalize our content and the advertising you see on this and other sites we also share this data with advertising, social media and analytics partners for the same purposes. By choosing “Accept All” you agree that we store cookies on your device and process the data for the aforementioned purposes . You may revoke your consent at any time by choosing the respective settings. For more information on the processing of personal data and what specific services we use see our Privacy Policy
Necessary Cookies
These cookies are required to provide you with our site and its functions. Since storing these cookies is necessary for the provision of our site and its functions, you cannot disable them. If you block these cookies via you browser settings our site may not function properly.
Analyse Cookies
These cookies enable us to use website analytics in order to improve our site or provide you with personalized content. They may be set by us or by third party providers whose services we have added to our pages.
Marketing Cookies
These cookies enable us to use online marketing and advertising in order to provide you on this or on other sites with personalized advertisement. They may be set by us or by third party providers whose services we have added to our pages.